Literature DB >> 32640171

You Say You Want a Resolution (of Fibrosis).

Kamran Atabai1,2,3, Christopher D Yang1, Michael J Podolsky1,2,3.   

Abstract

In pathological fibrosis, aberrant tissue remodeling with excess extracellular matrix leads to organ dysfunction and eventual morbidity. Diseases of fibrosis create significant global health and economic burdens and are often deadly. Although fibrosis has traditionally been thought of as an irreversible process, a growing body of evidence demonstrates that organ fibrosis can reverse in certain circumstances, especially if an underlying cause of injury can be removed. This body of evidence has uncovered more and more contributors to persistent and nonresolving tissue fibrosis. Here, we review the present knowledge on resolution of organ fibrosis and restoration of near-normal tissue architecture. We emphasize three critical areas of tissue homeostasis that are necessary for fibrosis resolution, namely, the elimination of matrix-producing cells, the clearance of excess matrix, and the regeneration of normal tissue constituents. In so doing, we also highlight how profibrotic pathways interact with one another and where there may be therapeutic opportunities to intervene and remediate pathological persistent fibrosis.

Entities:  

Keywords:  extracellular matrix turnover; fibroblasts; fibrosis; pulmonary fibrosis; resolution of fibrosis

Mesh:

Year:  2020        PMID: 32640171      PMCID: PMC7528922          DOI: 10.1165/rcmb.2020-0182TR

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  185 in total

1.  Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.

Authors:  Jeffrey C Horowitz; Iyabode O Ajayi; Priya Kulasekaran; David S Rogers; Joshua B White; Sarah K Townsend; Eric S White; Richard S Nho; Peter D R Higgins; Steven K Huang; Thomas H Sisson
Journal:  Int J Biochem Cell Biol       Date:  2011-10-25       Impact factor: 5.085

2.  Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.

Authors:  Yan Y Sanders; Annie Pardo; Moisés Selman; Gerard J Nuovo; Trygve O Tollefsbol; Gene P Siegal; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-12       Impact factor: 6.914

3.  Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.

Authors:  Vivian Barry-Hamilton; Rhyannon Spangler; Derek Marshall; Scott McCauley; Hector M Rodriguez; Miho Oyasu; Amanda Mikels; Maria Vaysberg; Haben Ghermazien; Carol Wai; Carlos A Garcia; Arleene C Velayo; Brett Jorgensen; Donna Biermann; Daniel Tsai; Jennifer Green; Shelly Zaffryar-Eilot; Alison Holzer; Scott Ogg; Dung Thai; Gera Neufeld; Peter Van Vlasselaer; Victoria Smith
Journal:  Nat Med       Date:  2010-09-05       Impact factor: 53.440

4.  Stiff matrix instigates type I collagen biogenesis by mammalian cleavage factor I complex-mediated alternative polyadenylation.

Authors:  Zijing Zhou; Jing Qu; Li He; Yi Zhu; Shan-Zhong Yang; Feng Zhang; Ting Guo; Hong Peng; Ping Chen; Yong Zhou
Journal:  JCI Insight       Date:  2020-02-13

5.  Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.

Authors:  A M Cantin; S L North; G A Fells; R C Hubbard; R G Crystal
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

Authors:  G A McQuibban; G S Butler; J H Gong; L Bendall; C Power; I Clark-Lewis; C M Overall
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

7.  Fibrotic extracellular matrix activates a profibrotic positive feedback loop.

Authors:  Matthew W Parker; Daniel Rossi; Mark Peterson; Karen Smith; Kristina Sikström; Eric S White; John E Connett; Craig A Henke; Ola Larsson; Peter B Bitterman
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

8.  Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis.

Authors:  L A Borthwick; L Barron; K M Hart; K M Vannella; R W Thompson; S Oland; A Cheever; J Sciurba; T R Ramalingam; A J Fisher; T A Wynn
Journal:  Mucosal Immunol       Date:  2015-04-29       Impact factor: 7.313

9.  Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.

Authors:  Naoki Ikenaga; Zhen-Wei Peng; Kahini A Vaid; Susan B Liu; Shuhei Yoshida; Deanna Y Sverdlov; Amanda Mikels-Vigdal; Victoria Smith; Detlef Schuppan; Yury V Popov
Journal:  Gut       Date:  2017-01-10       Impact factor: 23.059

10.  Principles of Cell Circuits for Tissue Repair and Fibrosis.

Authors:  Miri Adler; Avi Mayo; Xu Zhou; Ruth A Franklin; Matthew L Meizlish; Ruslan Medzhitov; Stefan M Kallenberger; Uri Alon
Journal:  iScience       Date:  2020-01-16
View more
  7 in total

Review 1.  Update in Interstitial Lung Disease 2020.

Authors:  Anna J Podolanczuk; Alyson W Wong; Shigeki Saito; Joseph A Lasky; Christopher J Ryerson; Oliver Eickelberg
Journal:  Am J Respir Crit Care Med       Date:  2021-06-01       Impact factor: 21.405

2.  Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice.

Authors:  Jing Qu; Shan-Zhong Yang; Yi Zhu; Ting Guo; Victor J Thannickal; Yong Zhou
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

3.  Stimulation of Synthesis and Lysis of Extracellular Matrix Proteins in Fibrosis Associated with Lymphedema.

Authors:  Jose Maria Pereira de Godoy; Maria de Fatima Guerreiro Godoy; Henrique Jose Pereira de Godoy; Dalisio De Santi Neto
Journal:  Dermatopathology (Basel)       Date:  2021-12-28

4.  Physiological Stimulation of the Synthesis of Preelastic Fibers in the Dermis of a Patient with Fibrosis.

Authors:  Jose Maria Pereira de Godoy; Lívia Maria Pereira de Godoy; Maria de Fatima Guerreiro Godoy; Dalisio de Santi Neto
Journal:  Case Rep Med       Date:  2021-12-30

5.  The M2a Macrophage Phenotype Accompanies Pulmonary Granuloma Resolution in Mmp12 Knock-Out Mice Instilled with Multiwall Carbon Nanotubes.

Authors:  David Ogburn; Sophia Bhalla; Nan Leffler; Arjun Mohan; Anagha Malur; Achut G Malur; Matthew McPeek; Barbara P Barna; Mary Jane Thomassen
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 6.208

Review 6.  New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction.

Authors:  Xiangyu Zhao; Jiayin Chen; Hongxiang Sun; Yao Zhang; Duowu Zou
Journal:  Cell Biosci       Date:  2022-07-27       Impact factor: 9.584

Review 7.  Irreversibility of Pulmonary Fibrosis.

Authors:  Qing Yang Yu; Xiao Xiao Tang
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.